A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer. - Knox JJ; McNamara MG; Bazin IS; Oh DY; Zubkov O; Breder V; Bai LY; Christie A; Goyal L; Cosgrove DP; Springfeld C; Sjoquist KM; et al. (Journal of hepatology, 2025)